查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552648

鼻用皮质类固醇市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Nasal Corticosteroids Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 156 Pages | 商品交期: 2-10个工作天内

价格

鼻用皮质类固醇市场 - 报告范围

TMR 关于全球鼻用皮质类固醇市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 -2034年期间，考虑2024年为基准年，2034年为预测年。该报告也提供了2024年至2034年全球鼻用皮质类固醇市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。次要研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解鼻用皮质类固醇市场。

市场概况
2023年市场价值 66 亿美元
2034 年市场价值 114 亿美元
复合年增长率 5.2%

该报告深入研究了全球鼻用皮质类固醇市场的竞争格局。全球鼻用皮质类固醇市场的主要参与者已经确定，并且每一位参与者都根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球鼻用皮质类固醇市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：按药物类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依药物类型，2020-2034
    • 丙酸氟替卡松
    • 布地奈德
    • 二丙酸倍氯米松
    • 糠酸莫米松
    • 曲安奈德
    • 环索奈德
    • 氟尼缩松
    • 替索皮质醇
  • 市场吸引力：按药物类型

第 7 章：全球市场分析与预测：依指标类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依指标类型，2020-2034
    • 过敏性鼻炎 (AR)
      • 季节性 AR
      • 常年AR
    • 非过敏性鼻炎 (NAR)
      • 传染性NAR
      • 血管舒缩神经元
      • 萎缩性NAR
  • 市场吸引力：依指示类型

第 8 章：全球市场分析与预测：按类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按类型，2020-2034
    • 处方药
    • 非处方药
  • 市场吸引力：按类型

第 9 章：全球市场分析与预测：按剂型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按剂型，2020-2034年
    • 鼻内滴剂
    • 鼻内喷剂
  • 市场吸引力：按剂型

第 10 章：全球市场分析与预测：按配销通路

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2020-2034
    • 医院药房
    • 零售药局
    • 网路药局
  • 市场吸引力：按配销通路划分

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 12 章：北美市场分析与预测

第 13 章：欧洲市场分析与预测

第 14 章：亚太市场分析与预测

第 15 章：拉丁美洲市场分析与预测

第 16 章：中东和非洲市场分析与预测

第17章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司分类（2023）
  • 公司简介
    • Merck & Co., Inc.
    • GSK plc
    • AstraZeneca
    • Sanofi SA
    • Perrigo Company plc
    • Teva Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals Limited
    • Mylan NV
    • Novartis AG
    • Pfizer Inc.
    • Pharmascience Inc.
Product Code: TMRGL86315

Nasal Corticosteroids Market - Scope of Report

TMR's report on the global nasal corticosteroids market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global nasal corticosteroids market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nasal corticosteroids market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nasal corticosteroids market.

Market Snapshot
Market Value in 2023US$ 6.6 Bn
Market Value in 2034US$ 11.4 Bn
CAGR5.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nasal corticosteroids market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nasal corticosteroids market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nasal corticosteroids market.

The report delves into the competitive landscape of the global nasal corticosteroids market. Key players operating in the global nasal corticosteroids market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nasal corticosteroids market profiled in this report.

Key Questions Answered in Global nasal corticosteroids Market Report:

  • What is the sales/revenue generated by nasal corticosteroids across all regions during the forecast period?
  • What are the opportunities in the global nasal corticosteroids market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nasal Corticosteroids Market - Research Objectives and Research Approach

The comprehensive report on the global nasal corticosteroids market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nasal corticosteroids market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nasal corticosteroids market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nasal Corticosteroids Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nasal Corticosteroids Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Nasal Corticosteroids Market Analysis and Forecast, by Drug Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Drug Type, 2020-2034
    • 6.3.1. Fluticasone Propionate
    • 6.3.2. Budesonide
    • 6.3.3. Beclomethasone Dipropionate
    • 6.3.4. Mometasone Furoate
    • 6.3.5. Triamcinolone Acetonide
    • 6.3.6. Ciclesonide
    • 6.3.7. Flunisolide
    • 6.3.8. Tixocortol
  • 6.4. Market Attractiveness, by Drug Type

7. Global Nasal Corticosteroids Market Analysis and Forecast, by Indication Type

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Indication Type, 2020-2034
    • 7.3.1. Allergic Rhinitis (AR)
      • 7.3.1.1. Seasonal AR
      • 7.3.1.2. Perennial AR
    • 7.3.2. Non-allergic Rhinitis (NAR)
      • 7.3.2.1. Infectious NAR
      • 7.3.2.2. Vasomotor NAR
      • 7.3.2.3. Atropic NAR
  • 7.4. Market Attractiveness, by Indication Type

8. Global Nasal Corticosteroids Market Analysis and Forecast, By Type

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, By Type, 2020-2034
    • 8.3.1. Prescription Drugs
    • 8.3.2. Over-the-Counter Drugs
  • 8.4. Market Attractiveness, By Type

9. Global Nasal Corticosteroids Market Analysis and Forecast, by Dosage Form

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Dosage Form, 2020-2034
    • 9.3.1. Intranasal Drops
    • 9.3.2. Intranasal Sprays
  • 9.4. Market Attractiveness, by Dosage Form

10. Global Nasal Corticosteroids Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Attractiveness, by Distribution Channel

11. Global Nasal Corticosteroids Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2020-2034
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Nasal Corticosteroids Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Drug Type, 2020-2034
    • 12.2.1. Fluticasone Propionate
    • 12.2.2. Budesonide
    • 12.2.3. Beclomethasone Dipropionate
    • 12.2.4. Mometasone Furoate
    • 12.2.5. Triamcinolone Acetonide
    • 12.2.6. Ciclesonide
    • 12.2.7. Flunisolide
    • 12.2.8. Tixocortol
  • 12.3. Market Attractiveness, by Drug Type
  • 12.4. Market Value Forecast, by Indication Type, 2020-2034
    • 12.4.1. Allergic Rhinitis (AR)
      • 12.4.1.1. Seasonal AR
      • 12.4.1.2. Perennial AR
    • 12.4.2. Non-allergic Rhinitis (NAR)
      • 12.4.2.1. Infectious NAR
      • 12.4.2.2. Vasomotor NAR
      • 12.4.2.3. Atropic NAR
  • 12.5. Market Attractiveness, by Indication Type
  • 12.6. Market Value Forecast, By Type, 2020-2034
    • 12.6.1. Prescription Drugs
    • 12.6.2. Over-the-Counter Drugs
  • 12.7. Market Attractiveness, By Type
  • 12.8. Market Value Forecast, by Dosage Form, 2020-2034
    • 12.8.1. Intranasal Drops
    • 12.8.2. Intranasal Sprays
  • 12.9. Market Attractiveness, by Dosage Form
  • 12.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.10.1. Hospital Pharmacies
    • 12.10.2. Retail Pharmacies
    • 12.10.3. Online Pharmacies
  • 12.11. Market Attractiveness, by Distribution Channel
  • 12.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Drug Type
    • 12.13.2. By Indication Type
    • 12.13.3. By Type
    • 12.13.4. By Dosage Form
    • 12.13.5. By Distribution Channel
    • 12.13.6. By Country

13. Europe Nasal Corticosteroids Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Drug Type, 2020-2034
    • 13.2.1. Fluticasone Propionate
    • 13.2.2. Budesonide
    • 13.2.3. Beclomethasone Dipropionate
    • 13.2.4. Mometasone Furoate
    • 13.2.5. Triamcinolone Acetonide
    • 13.2.6. Ciclesonide
    • 13.2.7. Flunisolide
    • 13.2.8. Tixocortol
  • 13.3. Market Attractiveness, by Drug Type
  • 13.4. Market Value Forecast, by Indication Type, 2020-2034
    • 13.4.1. Allergic Rhinitis (AR)
      • 13.4.1.1. Seasonal AR
      • 13.4.1.2. Perennial AR
    • 13.4.2. Non-allergic Rhinitis (NAR)
      • 13.4.2.1. Infectious NAR
      • 13.4.2.2. Vasomotor NAR
      • 13.4.2.3. Atropic NAR
  • 13.5. Market Attractiveness, by Indication Type
  • 13.6. Market Value Forecast, By Type, 2020-2034
    • 13.6.1. Intranasal Drops
    • 13.6.2. Intranasal Sprays
  • 13.7. Market Attractiveness, By Type
  • 13.8. Market Value Forecast, by Dosage Form, 2020-2034
    • 13.8.1. Companion Animal
    • 13.8.2. Livestock Animal
  • 13.9. Market Attractiveness, by Dosage Form
  • 13.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.10.1. Hospital Pharmacies
    • 13.10.2. Retail Pharmacies
    • 13.10.3. Online Pharmacies
  • 13.11. Market Attractiveness, by Distribution Channel
  • 13.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Drug Type
    • 13.13.2. By Indication Type
    • 13.13.3. By Type
    • 13.13.4. By Dosage Form
    • 13.13.5. By Distribution Channel
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Nasal Corticosteroids Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Drug Type, 2020-2034
    • 14.2.1. Fluticasone Propionate
    • 14.2.2. Budesonide
    • 14.2.3. Beclomethasone Dipropionate
    • 14.2.4. Mometasone Furoate
    • 14.2.5. Triamcinolone Acetonide
    • 14.2.6. Ciclesonide
    • 14.2.7. Flunisolide
    • 14.2.8. Tixocortol
  • 14.3. Market Attractiveness, by Drug Type
  • 14.4. Market Value Forecast, by Indication Type, 2020-2034
    • 14.4.1. Allergic Rhinitis (AR)
      • 14.4.1.1. Seasonal AR
      • 14.4.1.2. Perennial AR
    • 14.4.2. Non-allergic Rhinitis (NAR)
      • 14.4.2.1. Infectious NAR
      • 14.4.2.2. Vasomotor NAR
      • 14.4.2.3. Atropic NAR
  • 14.5. Market Attractiveness, by Indication Type
  • 14.6. Market Value Forecast, By Type, 2020-2034
    • 14.6.1. Prescription Drugs
    • 14.6.2. Over-the-Counter Drugs
  • 14.7. Market Attractiveness, By Type
  • 14.8. Market Value Forecast, by Dosage Form, 2020-2034
    • 14.8.1. Intranasal Drops
    • 14.8.2. Intranasal Sprays
  • 14.9. Market Attractiveness, by Dosage Form
  • 14.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 14.10.1. Hospital Pharmacies
    • 14.10.2. Retail Pharmacies
    • 14.10.3. Online Pharmacies
  • 14.11. Market Attractiveness, by Distribution Channel
  • 14.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Drug Type
    • 14.13.2. By Indication Type
    • 14.13.3. By Type
    • 14.13.4. By Dosage Form
    • 14.13.5. By Distribution Channel
    • 14.13.6. By Country/Sub-region

15. Latin America Nasal Corticosteroids Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Drug Type, 2020-2034
    • 15.2.1. Fluticasone Propionate
    • 15.2.2. Budesonide
    • 15.2.3. Beclomethasone Dipropionate
    • 15.2.4. Mometasone Furoate
    • 15.2.5. Triamcinolone Acetonide
    • 15.2.6. Ciclesonide
    • 15.2.7. Flunisolide
    • 15.2.8. Tixocortol
  • 15.3. Market Attractiveness, by Drug Type
  • 15.4. Market Value Forecast, by Indication Type, 2020-2034
    • 15.4.1. Allergic Rhinitis (AR)
      • 15.4.1.1. Seasonal AR
      • 15.4.1.2. Perennial AR
    • 15.4.2. Non-allergic Rhinitis (NAR)
      • 15.4.2.1. Infectious NAR
      • 15.4.2.2. Vasomotor NAR
      • 15.4.2.3. Atropic NAR
  • 15.5. Market Attractiveness, by Indication Type
  • 15.6. Market Value Forecast, By Type, 2020-2034
    • 15.6.1. Prescription Drugs
    • 15.6.2. Over-the-Counter Drugs
  • 15.7. Market Attractiveness, By Type
  • 15.8. Market Value Forecast, by Dosage Form, 2020-2034
    • 15.8.1. Intranasal Drops
    • 15.8.2. Intranasal Sprays
  • 15.9. Market Attractiveness, by Dosage Form
  • 15.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 15.10.1. Hospital Pharmacies
    • 15.10.2. Retail Pharmacies
    • 15.10.3. Online Pharmacies
  • 15.11. Market Attractiveness, by Distribution Channel
  • 15.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Drug Type
    • 15.13.2. By Indication Type
    • 15.13.3. By Type
    • 15.13.4. By Dosage Form
    • 15.13.5. By Distribution Channel
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Nasal Corticosteroids Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Drug Type, 2020-2034
    • 16.2.1. Fluticasone Propionate
    • 16.2.2. Budesonide
    • 16.2.3. Beclomethasone Dipropionate
    • 16.2.4. Mometasone Furoate
    • 16.2.5. Triamcinolone Acetonide
    • 16.2.6. Ciclesonide
    • 16.2.7. Flunisolide
    • 16.2.8. Tixocortol
  • 16.3. Market Attractiveness, by Drug Type
  • 16.4. Market Value Forecast, by Indication Type, 2020-2034
    • 16.4.1. Allergic Rhinitis (AR)
      • 16.4.1.1. Seasonal AR
      • 16.4.1.2. Perennial AR
    • 16.4.2. Non-allergic Rhinitis (NAR)
      • 16.4.2.1. Infectious NAR
      • 16.4.2.2. Vasomotor NAR
      • 16.4.2.3. Atropic NAR
  • 16.5. Market Attractiveness, by Indication Type
  • 16.6. Market Value Forecast, By Type, 2020-2034
    • 16.6.1. Prescription Drugs
    • 16.6.2. Over-the-Counter Drugs
  • 16.7. Market Attractiveness, By Type
  • 16.8. Market Value Forecast, by Dosage Form, 2020-2034
    • 16.8.1. Intranasal Drops
    • 16.8.2. Intranasal Sprays
  • 16.9. Market Attractiveness, by Dosage Form
  • 16.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 16.10.1. Hospital Pharmacies
    • 16.10.2. Retail Pharmacies
    • 16.10.3. Online Pharmacies
  • 16.11. Market Attractiveness, by Distribution Channel
  • 16.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Drug Type
    • 16.13.2. By Indication Type
    • 16.13.3. By Type
    • 16.13.4. By Dosage Form
    • 16.13.5. By Distribution Channel
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2023)
  • 17.3. Company Profiles
    • 17.3.1. Merck & Co., Inc.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. GSK plc
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. AstraZeneca
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Sanofi S.A.
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Perrigo Company plc
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Teva Pharmaceutical Industries Ltd.
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Glenmark Pharmaceuticals Limited
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Mylan N.V.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Novartis AG
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Pfizer Inc.
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview
    • 17.3.11. Pharmascience Inc.
      • 17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.11.2. Product Portfolio
      • 17.3.11.3. Financial Overview
      • 17.3.11.4. SWOT Analysis
      • 17.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Drug Type, 2020-2034
  • Table 02: Global Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 03: Global Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
  • Table 04: Global Nasal Corticosteroids Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 05: Global Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 06: Global Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 07: North America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 08: North America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Drug Type, 2020-2034
  • Table 09: North America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 10: North America Nasal Corticosteroids Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 11: North America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
  • Table 12: North America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 13: Europe Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Europe Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Drug Type, 2020-2034
  • Table 15: Europe Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 16: Europe Nasal Corticosteroids Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 17: Europe Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
  • Table 18: Europe Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 19: Asia Pacific Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 20: Asia Pacific Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Drug Type, 2020-2034
  • Table 21: Asia Pacific Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 22: Asia Pacific Nasal Corticosteroids Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 23: Asia Pacific Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
  • Table 24: Asia Pacific Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 25: Latin America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 26: Latin America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Drug Type, 2020-2034
  • Table 27: Latin America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 28: Latin America Nasal Corticosteroids Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 29: Latin America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
  • Table 30: Latin America Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 31: Middle East & Africa Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 32: Middle East & Africa Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Drug Type, 2020-2034
  • Table 33: Middle East & Africa Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Indication Type, 2020-2034
  • Table 34: Middle East & Africa Nasal Corticosteroids Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 35: Middle East & Africa Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Dosage Form, 2020-2034
  • Table 36: Middle East & Africa Nasal Corticosteroids Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Nasal Corticosteroids Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Nasal Corticosteroids Market Revenue (US$ Bn), by Drug Type, 2023
  • Figure 03: Global Nasal Corticosteroids Market Value Share, by Drug Type, 2023
  • Figure 04: Global Nasal Corticosteroids Market Revenue (US$ Bn), by Indication Type, 2023
  • Figure 05: Global Nasal Corticosteroids Market Value Share, by Indication Type, 2023
  • Figure 06: Global Nasal Corticosteroids Market Revenue (US$ Bn), By Type, 2023
  • Figure 07: Global Nasal Corticosteroids Market Value Share, By Type, 2023
  • Figure 08: Global Nasal Corticosteroids Market Revenue (US$ Bn), by Dosage Form, 2023
  • Figure 09: Global Nasal Corticosteroids Market Value Share, by Dosage Form, 2023
  • Figure 10: Global Nasal Corticosteroids Market Revenue (US$ Bn), by Distribution Channel, 2023
  • Figure 11: Global Nasal Corticosteroids Market Value Share, by Distribution Channel, 2023
  • Figure 12: Global Nasal Corticosteroids Market Value Share, by Region, 2023
  • Figure 13: Global Nasal Corticosteroids Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 14: Global Nasal Corticosteroids Market Value Share Analysis, by Drug Type, 2023 and 2034
  • Figure 15: Global Nasal Corticosteroids Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 16: Global Nasal Corticosteroids Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 17: Global Nasal Corticosteroids Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 18: Global Nasal Corticosteroids Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 19: Global Nasal Corticosteroids Market Attractiveness Analysis, By Type, 2024-2034
  • Figure 20: Global Nasal Corticosteroids Market Revenue (US$ Bn), by Dosage Form, 2023
  • Figure 21: Global Nasal Corticosteroids Market Value Share, by Dosage Form, 2023
  • Figure 22: Global Nasal Corticosteroids Market Revenue (US$ Bn), by Distribution Channel, 2023
  • Figure 23: Global Nasal Corticosteroids Market Value Share, by Distribution Channel, 2023
  • Figure 24: Global Nasal Corticosteroids Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 25: Global Nasal Corticosteroids Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 26: North America Nasal Corticosteroids Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 27: North America Nasal Corticosteroids Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 28: North America Nasal Corticosteroids Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 29: North America Nasal Corticosteroids Market Value Share Analysis, by Drug Type, 2023 and 2034
  • Figure 30: North America Nasal Corticosteroids Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 31: North America Nasal Corticosteroids Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 32: North America Nasal Corticosteroids Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 33: North America Nasal Corticosteroids Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 34: North America Nasal Corticosteroids Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 35: North America Nasal Corticosteroids Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 36: North America Nasal Corticosteroids Market Attractiveness Analysis, By Type, 2023-2034
  • Figure 37: North America Nasal Corticosteroids Market Attractiveness Analysis, by Dosage Form, 2024-2034
  • Figure 38: North America Nasal Corticosteroids Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 39: Europe Nasal Corticosteroids Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 40: Europe Nasal Corticosteroids Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 41: Europe Nasal Corticosteroids Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 42: Europe Nasal Corticosteroids Market Value Share Analysis, by Drug Type, 2023 and 2034
  • Figure 43: Europe Nasal Corticosteroids Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 44: Europe Nasal Corticosteroids Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 45: Europe Nasal Corticosteroids Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 46: Europe Nasal Corticosteroids Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 47: Europe Nasal Corticosteroids Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 48: Europe Nasal Corticosteroids Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 49: Europe Nasal Corticosteroids Market Attractiveness Analysis, By Type, 2024-2034
  • Figure 50: Europe Nasal Corticosteroids Market Attractiveness Analysis, by Dosage Form, 2024-2034
  • Figure 51: Europe Nasal Corticosteroids Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 52: Asia Pacific Nasal Corticosteroids Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 53: Asia Pacific Nasal Corticosteroids Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 54: Asia Pacific Nasal Corticosteroids Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 55: Asia Pacific Nasal Corticosteroids Market Value Share Analysis, by Drug Type, 2023 and 2034
  • Figure 56: Asia Pacific Nasal Corticosteroids Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 57: Asia Pacific Nasal Corticosteroids Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 58: Asia Pacific Nasal Corticosteroids Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 59: Asia Pacific Nasal Corticosteroids Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 60: Asia Pacific Nasal Corticosteroids Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 61: Asia Pacific Nasal Corticosteroids Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 62: Asia Pacific Nasal Corticosteroids Market Attractiveness Analysis, By Type, 2024-2034
  • Figure 63: Asia Pacific Nasal Corticosteroids Market Attractiveness Analysis, by Dosage Form, 2024-2034
  • Figure 64: Asia Pacific Nasal Corticosteroids Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 65: Latin America Nasal Corticosteroids Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 66: Latin America Nasal Corticosteroids Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 67: Latin America Nasal Corticosteroids Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Latin America Nasal Corticosteroids Market Value Share Analysis, by Drug Type, 2023 and 2034
  • Figure 69: Latin America Nasal Corticosteroids Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 70: Latin America Nasal Corticosteroids Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 71: Latin America Nasal Corticosteroids Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 72: Latin America Nasal Corticosteroids Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 73: Latin America Nasal Corticosteroids Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 74: Latin America Nasal Corticosteroids Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 75: Latin America Nasal Corticosteroids Market Attractiveness Analysis, By Type, 2023-2034
  • Figure 76: Latin America Nasal Corticosteroids Market Attractiveness Analysis, by Dosage Form, 2024-2034
  • Figure 77: Latin America Nasal Corticosteroids Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 78: Middle East & Africa Nasal Corticosteroids Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 79: Middle East & Africa Nasal Corticosteroids Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 80: Middle East & Africa Nasal Corticosteroids Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 81: Middle East & Africa Nasal Corticosteroids Market Value Share Analysis, by Drug Type, 2023 and 2034
  • Figure 82: Middle East & Africa Nasal Corticosteroids Market Value Share Analysis, by Indication Type, 2023 and 2034
  • Figure 83: Middle East & Africa Nasal Corticosteroids Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 84: Middle East & Africa Nasal Corticosteroids Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 85: Middle East & Africa Nasal Corticosteroids Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 86: Middle East & Africa Nasal Corticosteroids Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 87: Middle East & Africa Nasal Corticosteroids Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 88: Middle East & Africa Nasal Corticosteroids Market Attractiveness Analysis, By Type, 2023-2034
  • Figure 89: Middle East & Africa Nasal Corticosteroids Market Attractiveness Analysis, by Dosage Form, 2024-2034
  • Figure 90: Middle East & Africa Nasal Corticosteroids Market Attractiveness Analysis, by Distribution Channel, 2024-2034